
Choisissez votre étiquette
affichée directement sur le flacon7 rapports de laboratoire
PDF- Testé
- Retatrutide 10mg
- Laboratoire
- Analiza Białek
- Date
- November 2026
- Résultat
- 99% purity (10.37 mg measured)
- Endotoxines
- 5.54 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 15mg
- Laboratoire
- Analiza Białek
- Date
- November 2026
- Résultat
- 99% purity (16.53 mg measured)
- Endotoxines
- 5.91 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 30mg
- Laboratoire
- Analiza Białek
- Date
- November 2026
- Résultat
- 99% purity (31.88 mg measured)
- Endotoxines
- 6.29 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 40mg
- Laboratoire
- Analiza Białek
- Date
- November 2026
- Résultat
- 99% purity (40.92 mg measured)
- Endotoxines
- 6.82 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 60mg
- Laboratoire
- Analiza Białek
- Date
- November 2026
- Résultat
- 99% purity (60.10 mg measured)
- Endotoxines
- 7.73 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 20mg
- Laboratoire
- Analiza Białek
- Date
- October 2026
- Résultat
- 99% purity (23.28 mg measured)
- Endotoxines
- 6.15 EU/vial
- N° de commande
- Mot de passe
PDF- Testé
- Retatrutide 5mg
- Laboratoire
- Analiza Białek
- Date
- July 2026
- Résultat
- 99% purity (5.28 mg measured)
- N° de commande
- Mot de passe
Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.
Retatrutide
GLP-1
- Testé en laboratoire · 99% de pureté
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
4.6 sur 5 sur Trustpilot73 avis
Aussi recherché sous : Retatrutid · Reta · LY3437943
En un coup d'œil
Retatrutide en chiffres
Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.
Article complet du lexiqueHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~6 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
~6days
- Class
- Triple agonistGLP-1 / GIP / glucagon
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 60 mg11 sizes in the shop
What studies show
All 10 sources in the lexicon- up to25 %
Phase 3 trial TRIUMPH-1 in obesity (up to 25% weight reduction at 80 weeks) (opens in a new tab)
Jastreboff et al., New England Journal of Medicine, 2026 - up to18.8 %Bellido et al., The Lancet, 2026
- up to~24 %
Phase 2 study in obesity (up to ~24% weight reduction at 48 weeks) (opens in a new tab)
Jastreboff et al., New England Journal of Medicine, 2023
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient Retatrutide.
Tous les avisConnaissances
Tout sur Retatrutide
Informations détaillées bientôt disponibles.
Dosage
Chargement des informations de dosage …
Bon à avoir
Ce dont vous avez besoin avec
L'eau bactériostatique est ajoutée automatiquement à votre panier. Seringues et tampons en un clic.
Seringues à insuline
10 pièces · 5.50 €
Tampons alcoolisés
50 pièces · 10 €
Combien d'eau ?
Unités sur la seringue pour la taille de votre flacon.
Ouvrir le calculateur →Is Retatrutide approved?
No, as of 25 October 2026 there is no approval. Retatrutide is in phase 3: 14 phase 3 trials are listed on ClinicalTrials.gov, five of them completed. The first phase 3 results were published in 2026.
How does Retatrutide differ from Tirzepatide and Semaglutide?
The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GLP-1 and GIP. Retatrutide also targets the glucagon receptor. In animal models this added higher energy expenditure. A head-to-head trial against Tirzepatide is still running (TRIUMPH-5).
What did the phase 3 trials show?
In TRIUMPH-1 (obesity without diabetes) weight fell by 25.0 percent on average after 80 weeks at the highest study dose, by 3.9 percent on placebo. In TRIUMPH-2 (with type 2 diabetes) it was 18.8 versus 5.1 percent. In TRANSCEND-T2D-1 long-term blood sugar (HbA1c) fell by up to 1.94 percentage points in 40 weeks.
What happens to liver fat?
In a substudy with fatty liver (MASLD) liver fat fell by about 81 to 82 percent after 24 weeks in the two higher levels. 86 percent reached normal liver fat below 5 percent at the highest level. A large phase 3 trial on liver disease runs until 2030.
Which side effects were seen?
Most often gastrointestinal effects such as nausea and diarrhoea, depending on the dose. In TRIUMPH-2 abnormal skin sensations (dysaesthesia) and low blood pressure occurred more often than on placebo. In the phase 2 trial heart rate rose in a dose-dependent way, most around week 24.
Which trials are still running?
Nine phase 3 trials are not finished yet. The largest: TRIUMPH-OUTCOMES on heart and kidney events with about 10,000 participants (planned end 2029) and SYNERGY-Outcomes on fatty liver (2030). The comparison with Tirzepatide (TRIUMPH-5) is due to reach its primary endpoint in November 2026.
Comparatifs
Comment il se compare
Produits associés
Produits similaires
Tirzepatide
Peptides · GLP-1 & perte de graisse GLP-1 & perte de graisse
10 tailles
Testé en laboratoire
= dès 10 €/fiole
Semaglutide
Peptides · GLP-1 & perte de graisse GLP-1 & perte de graisse
6 tailles
Testé en laboratoire
= dès 10 €/fiole
Mazdutide
Peptides · GLP-1 & perte de graisse GLP-1 & perte de graisse
2 tailles
= dès 32 €/fiole
Survodutide
Peptides · GLP-1 & perte de graisse GLP-1 & perte de graisse
1 taille
= 60.8 €/fiole
Retatrutide

